Testing effectiveness (Phase 2)Active Not RecruitingNCT03817398
What this trial is testing
Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia
Who this might be right for
Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive
Children's Oncology Group 110